A Computational Strategy for the Rapid Identification and Ranking of Patient-Specific T cell Receptors Bound to Neoantigens

T Cell Receptor (TCR) recognition of a peptide-major histocompatibility complex (pMHC) is crucial for adaptive immune response. The identification of therapeutically relevant TCR-pMHC protein pairs is a bottleneck in the implementation of TCR-based immunotherapies. The ability to computationally des...

Full description

Saved in:
Bibliographic Details
Published inMacromolecular rapid communications. p. e2400225
Main Authors Rollins, Zachary A, Curtis, Matthew B, George, Steven C, Faller, Roland
Format Journal Article
LanguageEnglish
Published Germany 05.06.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:T Cell Receptor (TCR) recognition of a peptide-major histocompatibility complex (pMHC) is crucial for adaptive immune response. The identification of therapeutically relevant TCR-pMHC protein pairs is a bottleneck in the implementation of TCR-based immunotherapies. The ability to computationally design TCRs to target a specific pMHC requires automated integration of next-generation sequencing, protein-protein structure prediction, molecular dynamics, and TCR ranking. We present a pipeline to evaluate patient-specific, sequence-based TCRs to a target pMHC. Using the three most frequently expressed TCRs from 16 colorectal cancer patients, we predict the protein-protein structure of the TCRs to the target CEA peptide-MHC using Modeller and ColabFold. TCR-pMHC structures are compared using automated equilibration and successive analysis. ColabFold generated configurations require a ∼2.5X reduction in equilibration time of TCR-pMHC structures compared to Modeller. The structural differences between Modeller and ColabFold are demonstrated by root mean square deviation (∼0.20 nm) between clusters of equilibrated configurations, which impact the number of hydrogen bonds and Lennard-Jones contacts between the TCR and pMHC. We identify TCR ranking criteria that may prioritize TCRs for evaluation of in vitro immunogenicity and validate this ranking by comparing to state-of-the-art machine learning based methods trained to predict the probability of TCR-pMHC binding. This article is protected by copyright. All rights reserved.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1521-3927
DOI:10.1002/marc.202400225